Skip to main content

This website is no longer being updated. Visit Dartmouth Now for all news published after June 7, 2010.


Dartmouth News
>  News Releases >   2005 >   November

Dartmouth professor speaks to FDA about prescription drug advertising

Dartmouth College Office of Public Affairs • Press Release
Posted 11/04/05 • Contact Susan Knapp (603) 646-3661

Lewis Glinert
Professor Lewis Glinert (photo by Joseph Mehling '69)

On November 1, Professor Lewis Glinert participated in a Federal Drug Administration-hosted panel presentation in Washington D.C. about direct-to-consumer (DTC) drug advertising. Glinert, a linguistics expert and a professor of Asian and Middle Eastern languages and literature, offered comments on his recent studies that examined how the benefits and risks of drugs are communicated during television advertisements.

Officials at the FDA invited Glinert to speak at this two-day public hearing, which offered an opportunity for public participation and comment on DTC promotion of regulated medical products.

"This is an important issue, and I'm glad that the FDA wanted to hear from so many different constituents regarding DTC advertising," says Glinert. "The experience was synergic and may mark a turning point in health education."

Read Glinert's presentation: "Among the public's many concerns about televised drug advertising, the provision of risk information stands out."

Dartmouth has television (satellite uplink) and radio (ISDN) studios available for domestic and international live and taped interviews. For more information, call 603-646-3661 or see our Radio, Television capability webpage.

Recent Headlines from Dartmouth News: